ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 31, 2025 SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan […]

HyOrc Completes Factory Acceptance Test of 500kw ORC Turbine for International Customer

(Other OTC:HYOR),(OTC US:HYOR), HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCID: HYOR), a clean-energy technology company, today announced the successful completion of the Factory Acceptance Test (FAT) for its 500kW Organic Rankine Cycle (ORC) turbine, which is now being prepared for shipment to Camsan Ordu, a customer project in Turkey. The FAT was

HyOrc Completes Factory Acceptance Test of 500kw ORC Turbine for International Customer

HyOrc Completes Factory Acceptance Test of 500kw ORC Turbine for International Customer GlobeNewswire December 31, 2025 HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCID: HYOR), a clean-energy technology company, today announced the successful completion of the Factory Acceptance Test (FAT) for its 500kW Organic Rankine Cycle (ORC) turbine, which is now being prepared

Reeflex Solutions Inc. Granted Management Cease Trade Order and Provides Bi-Weekly Status Update

(TSX-V:RFX), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — Reeflex Solutions Inc. (TSXV: RFX) (“Reeflex” or the “Company“) announces that, further to its announcement on December 17, 2025, the Alberta Securities Commission (the “ASC“), as principal regulator of the Company, has

Reeflex Solutions Inc. Granted Management Cease Trade Order and Provides Bi-Weekly Status Update

Reeflex Solutions Inc. Granted Management Cease Trade Order and Provides Bi-Weekly Status Update GlobeNewswire December 31, 2025 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — Reeflex Solutions Inc. (TSXV: RFX) (“Reeflex” or the “Company“) announces that, further to its announcement on

Columbia Banking System Announces Date of Fourth Quarter 2025 Earnings Release and Conference Call

Columbia Banking System, Inc. (“Columbia” Nasdaq: COLB), parent company of Columbia Bank, today announced it will release fourth quarter 2025 financial results on Thursday, January 22, 2026, after market close. The Company will host a conference call for investors and analysts at 2:00 p.m. PT (5:00 p.m. ET) that same day. During the call, management

Donna Rae Garff Marriott, Cherished Wife, Mother, Grandmother, and Community Leader, Passes Away at Age 90

Marriott International announces with deep sadness the passing of Donna RaeGarff Marriott, a woman of grace, faith, and unwavering devotion to family. Mrs. Marriott passed away peacefully on December 30, 2025, surrounded by loved ones. She and J.W. “Bill” Marriott, Jr., Chairman Emeritus of Marriott International, recently celebrated their 70th wedding anniversary. https://mma.prnewswire.com/media/2853054/Marriott_International_Inc___Donna_Marriott.jpg Born June

Canadian Investment Regulatory Organization Trading Halt – FSZ.DB.B

The following issues have been halted by CIRO: Company: Fiera Capital Corporation TSX Symbol: FSZ.DB.B All Issues: No Reason:Pending Delisting Halt Time (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly

Canadian Investment Regulatory Organization Trading Halt – AI.DB.D

The following issues have been halted by CIRO: Company: Atrium Mortgage Investment Corporation TSX Symbol: AI.DB.D All Issues: No Reason: Pending Delisting Halt Time (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair

The End of Shots? 5 Biotech Stocks Rethinking Diabetes

Issued on behalf of Avant Technologies Inc. USA News Group News Commentary – Recent clinical trials achieving 83% insulin independence rates have ignited a dramatic shift in metabolic disease investment[1], with late-2025 M&A activity reaching record valuations as major pharmaceutical companies race to secure curative platforms over symptom-management franchises[2]. This pivot toward functional cures rather

Scroll to Top